Kendall Healthcare Products Co.

The FDA’s addition of post-exposure prophylaxis for COVID-19 to the emergency use authorization for Regeneron Pharmaceuticals, Inc. ’s monoclonal antibody therapy REGEN-COV (casirivimab and imdevimab

Regeneron Pharmaceuticals, Inc. reported stellar second quarter sales and earnings on 5 August with revenues up 163% to $5.14bn, powered by $2.76bn in revenues from REGEN-COV, the antibody cocktail f

AstraZeneca has unveiled disappointing results from its STORM CHASER study, the first read-out from its contender in the COVID-19 antibody therapy field, AZD7442. The result means that AstraZeneca ha

Vir Biotechnology and GlaxoSmithKline 's COVID-19 antibody therapy sotrovimab has been given the green light for use in the European Union. The EU regulator’s committee for human medicinal products